Quick Takeaways
- Drugs Made In America Acquisition LLC filed SCHEDULE 13D for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA).
- Disclosed ownership: 12%.
- Date of event: 18 Feb 2025.
Drugs Made In America Acquisition LLC - 18 Feb 2025 SCHEDULE 13D Report for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)
- Filing Manager
- Drugs Made In America Acquisition LLC
- Reporting Manager
- Drugs Made In America Acquisition LLC
- Symbol
- DMAA
- Shares outstanding
- 33,510,240 shares
- Disclosed Ownership
- 4,188,780 shares
- Ownership
- 12%
- Form type
- SCHEDULE 13D
- Filing time
- 03 Mar 2025, 18:37:52 UTC
- Date of event
- 18 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Drugs Made In America Acquisition LLC disclosed 12% ownership in Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) on 18 Feb 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Mar 2025, 18:37.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Drugs Made In America Acquisition LLC | 12% | 4,188,780 | 4,188,780 | 0 | Drugs Made In America Acquisition LLC /s/ Lynn Stockwell | Lynn Stockwell, Managing Member | 0002038492 |
| Lynn Stockwell | 12% | 4,188,780 | 4,188,780 | 0 | /s/ Lynn Stockwell | Lynn Stockwell | 0001927032 |